Averna Therapeutics is a genetic-medicine biotechnology company creating what it calls the last, great missing tool required to break through the most persistent barriers in genetic medicine. Backed by Insight Partners, the company was recognized as an Endpoints 11 Most Promising Biotech Company in 2025 and has presented at the 44th Annual J.P. - View it on GitHub